122 related articles for article (PubMed ID: 1164407)
1. Combination chemotherapy in Hodgkin's disease: relation to radiotherapy.
Rosenberg SA
Bibl Haematol; 1975; (40):731-5. PubMed ID: 1164407
[TBL] [Abstract][Full Text] [Related]
2. A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease.
Huguley CM; Durant JR; Moores RR; Chan YK; Dorfman RF; Johnson L
Cancer; 1975 Oct; 36(4):1227-40. PubMed ID: 1175125
[TBL] [Abstract][Full Text] [Related]
3. The management of stages I, II, and III Hodgkin's disease with combined radiotherapy and chemotherapy.
Rosenberg SA; Kaplan HS
Cancer; 1975 Jan; 35(1):55-63. PubMed ID: 803252
[TBL] [Abstract][Full Text] [Related]
4. Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation.
Br Med J; 1975 Aug; 3(5980):413-4. PubMed ID: 1098721
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy-radiotherapy association in the treatment of localized forms of Hodgkin's disease. Prognosis of polychemotherapy after three trials of M.O.P.P].
Baillet F; Brun B; Mazeron JJ; Rochant H; Pinon G; Reyes F; Vernant JP; Pierquin B; Dreyfus B
Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):457-61. PubMed ID: 917834
[TBL] [Abstract][Full Text] [Related]
6. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
Aghai E; Kende G; Many A; Ramot B
Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045
[No Abstract] [Full Text] [Related]
7. The therapeutic implications of splenic involvement in stage IIIA Hodgkin's disease.
Levi JA; Wiernik PH
Cancer; 1977 May; 39(5):2158-65. PubMed ID: 404027
[TBL] [Abstract][Full Text] [Related]
8. Prednisone in MOPP chemotherapy for Hodgkin's disease.
Jacobs C; Portlock CS; Rosenberg SA
Br Med J; 1976 Dec; 2(6050):1469-71. PubMed ID: 1000259
[TBL] [Abstract][Full Text] [Related]
9. [81 cases of Hodgkin's disease treated with extensive radiotherapy, including 65 with primary MOPP chemiotherapy (author's transl)].
Baillet F; Brun B; Maylin C; Mazeron JJ; Pierquin B; Dreyfus B
J Radiol Electrol Med Nucl; 1977 May; 58(5):343-6. PubMed ID: 886528
[TBL] [Abstract][Full Text] [Related]
10. Combination chemotherapy and survival in advanced Hodgkin's disease.
Canellos GP; Young RC; Berard CW; DeVita VT
Arch Intern Med; 1973 Mar; 131(3):388-90. PubMed ID: 4569375
[No Abstract] [Full Text] [Related]
11. Combination chemotherapy of Hodgkin's disease.
Nison DW; Aisenberg AC
Cancer; 1974 Jun; 33(6):1499-504. PubMed ID: 4834147
[No Abstract] [Full Text] [Related]
12. [The current state of curability of Hodgkin's disease].
Streuli RA; Ultmann JE
Schweiz Med Wochenschr; 1981 Sep; 111(36):1301-3. PubMed ID: 7302531
[TBL] [Abstract][Full Text] [Related]
13. Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease.
Bonadonna G; Zucali R; De Lena M; Valagussa P
Cancer Treat Rep; 1977 Aug; 61(5):769-77. PubMed ID: 70270
[No Abstract] [Full Text] [Related]
14. Combination chemotherapy of advanced Hodgkin's disease. A review.
Goldsmith MA; Carter SK
Cancer; 1974 Jan; 33(1):1-8. PubMed ID: 4129559
[No Abstract] [Full Text] [Related]
15. Combination radiotherapy and chemotherapy in the treatment of early Hodgkin's disease.
Brace K; Serpick AA; Block JB; Wiernik PH
Oncology; 1973; 27(6):484-92. PubMed ID: 4582588
[No Abstract] [Full Text] [Related]
16. MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients.
Moore MR; Jones SE; Bull JM; William LA; Rosenberg SA
Cancer; 1973 Jul; 32(1):52-60. PubMed ID: 4716784
[No Abstract] [Full Text] [Related]
17. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
[TBL] [Abstract][Full Text] [Related]
18. [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
Osieka R; Bruntsch U; Gallmeier WM; Seeber S; Schmidt CG
Dtsch Med Wochenschr; 1976 Aug; 101(32):1177-82. PubMed ID: 59661
[TBL] [Abstract][Full Text] [Related]
19. Combined modality therapy of Hodgkin's disease: a report on the Stanford Trials.
Rosenberg SA; Kaplan HS; Portlock CS; Glatstein EJ
Cancer; 1978 Aug; 42(2 Suppl):991-1000. PubMed ID: 99226
[TBL] [Abstract][Full Text] [Related]
20. A Southwest Oncology Group: chemotherapy versus chemotherapy plus radiotherapy in treatment of stage III Hodgkin's disease.
Grozea PN; De Persio EJ; Coltman CA; Fabian CJ; Morrison FS; Gehan EA; Jones SE
Recent Results Cancer Res; 1982; 80():83-91. PubMed ID: 6173904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
